Sinocyclocheilus rhinocerous
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| A0A673GZZ0 | Pannexin 1 |
|
1 | 0 |
|
| A0A673NEJ3 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A673KRA7 | P2X purinoceptor 5-like |
|
1 | 0 |
|
| D2CRJ0 | Rhodopsin |
|
2 | 0 |
|
| A0A673NL54 | Hyaluronidase |
|
1 | 0 |
|
| A0A673N7H6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A673HP16 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A673J657 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A673MD15 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A673GJQ6 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
| A0A673H471 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A673MH30 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A673MRQ4 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
| A0A673ISV9 | Rhodopsin |
|
2 | 0 |
|
| A0A673NHJ3 | Hyaluronidase |
|
1 | 0 |
|
| A0A673I3A8 | Voltage-dependent N-type calcium channel subunit alpha-1B |
|
1 | 0 |
|
| A0A673IEV5 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
| A0A673J2B0 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A673LWG9 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
| A0A673IB57 | Voltage-dependent N-type calcium channel subunit alpha-1B |
|
1 | 0 |
|
| A0A673HC68 | Rhodopsin |
|
2 | 0 |
|
| A0A673GX66 | Hemopexin |
|
1 | 0 |
|
| A0A673NGY8 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A673NCX5 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A673IBN9 | Hyaluronidase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025